Dapsone Use in Patients With Aneurysmal Subarachnoid Hemorrhage.
Status:
Completed
Trial end date:
2009-03-10
Target enrollment:
Participant gender:
Summary
Dapsone is a drug that has been used clinically for several decades due to its anti-infective
effect, making it widely available. Its neuroprotective effects have been found through its
glutamate receptors antagonistic effect. Their main objective was to study the
neuroprotective properties in patients with aneurysmal subarachnoid hemorrhage and high-risk
factors for the development of cerebral vasospasm. Both the placebo and the dapsone used in
this clinical trial were provided by the institution's neurochemistry laboratory.
Phase:
Phase 3
Details
Lead Sponsor:
El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez